You are here

Radial Arterde Ateroskleroz’un Tahmini ve Etki Eden Risk Faktörleri

The Prediction of Atherosclerosis in Radial Artery and Affecting Risk Factors

Journal Name:

Publication Year:

Abstract (2. Language): 
In this study, the prediction of atherosclerosis in radial artery in patients with coronary artery disease and risk factors affecting atherosclerosis were studied. The data of the Group 1 which consist of ten patients for whom atherosclerosis was determined in radial artery were compared with the data of Group 2 which consist of fifteen patients for whom atherosclerosis does not exist. Nineteen clinical parameters containing age, gender, diabetes mellitus, hypertension, smoking, obesity, family history, collesterol, triglyceride, high density lipoprotein, low density lipoprotein, very low density lipoprotein, apoprotein A, apoprotein B, lipoprotein A, C-reactive protein, catalase, glutathione peroxidase and superoxide dismutase variables were obtained from the groups. The groups were compared statistically. Also, univariate and multivariate logistic regression analysis were applied and the results were evaluated. As a result, the measurable values and proportions of the traditional and new risk factors are higher for atherosclerosis in radial artery in patients with coronary artery disease compared with coronary artery patients. It would be more useful that multivariate statistical methods should be applied to greater sample in the study of risk factors.
Abstract (Original Language): 
Bu çalışmada, koroner arter hastalarında greft olarak kullanılan radial arterde aterosklerozun tahmini ve etki eden risk faktörlerinin incelenmesi amaçlanmıştır. Radial arterde ateroskleroz saptanan 10 hastanın oluşturduğu grubun (Grup 1) verileri, radial arterde ateroskleroz saptanmayan 15 hastanın (Grup 2) verileriyle karşılaştırılmıştır. Hastaların yaş, cinsiyet, diabetes mellitus, hipertansiyon, sigara içme, obezite, aile öyküsü, kolesterol, trigliserit, yüksek dansiteli lipoprotein, düşük dansiteli lipoprotein, çok düşük dansiteli lipoprotein, apoprotein A, apoprotein B, lipoprotein A, C-reaktif protein, katalaz, glutat peroksidaz ve süperoksid dismutaz değişkenlerden oluşan on dokuz adet klinik parametre, Grup 1 ve 2’den elde edilmiştir. Risk faktörlerinin incelenmesinde gruplar istatistiksel olarak karşılaştırılmıştır. Ayrıca tek ve çok değişkenli lojistik regresyon analizi uygulanarak sonuçlar yorumlanmıştır. Sonuç olarak, geleneksel ve yeni risk faktörlerin ölçülebilen değer ve oranları, koroner arter hastalarına oranla radial arterde ateroskleroz saptanan koroner arter hastalarında daha yüksektir. Risk faktörlerinin incelenmesinde çok değişkenli istatistik yöntemlerinin daha büyük bir örnekte uygulanması daha yararlı olacaktır.
147-151

REFERENCES

References: 

1. Vaina S, Stefanadis C. Detection of the vulnerable coronary
atheromatous plaque. Where are we now? Int J Cardiovasc
Intervent 2005;7:75-87.
2. Akgül E, Aydemir K. İnflamasyon ve ateroskleroz. Türk
Kardiyoloji Seminerleri. 2003; 5: 492-505.
3. McGovern PG, Pankow JS, Shahar E, Doliszny KM, Folsom
AR, Blackburn H, Luepker RV. Recent trends in acute
coronary heart disease: mortality, morbidity, medical care, and
risk factors. The Minnesota Heart Survey Investigators. N
Engl J Med 1996;334:884-90.
4. Jousilahti P, Vartiainen E, Tuomilehto J, Pekkanen J, Puska P.
Effect of risk factors and changes in risk factors on coronary
mortality in three cohorts of middle-aged people in eastern
Finland. Am J Epidemiol 1995;141:50-60.
5. Executive Summary of The Third Report of The National
Cholesterol Education Program (NCEP) Expert Panel on
Detection, Evaluation, And Treatment of High Blood
Cholesterol In Adults (Adult Treatment Panel III). JAMA
2001;285:2486-97.
6. Anderson KM, Odell PM, Wilson PW, Kannel WB.
Cardiovascular disease risk profiles. Am Heart J
1991;121:293-8.
7. Wood D, De Backer G, Faergeman O, Graham I, Mancia G,
Pyorala K. Prevention of coronary heart disease in clinical
practice. Summary of recommendations of the Second Joint
Task Force of European and other Societies on Coronary
Prevention. Blood Press 1998;7:262-9.
8. Linton MF, Fazio S; National Cholesterol Education Program
(NCEP)-the third Adult Treatment Panel (ATP III). A
practical approach to risk assessment to prevent coronary Radial Arterde Ateroskleroz’un Tahmini ve Risk Faktörleri
151
artery disease and its complications. Am J Cardiol
2003;92:19-26.
9. Clinical Guidelines on the Identification, Evaluation, and
Treatment of Overweight and Obesity in Adults: The
Evidence Report. National Institutes of Health. Obes Res
1998;6 (Suppl 2):51S-209S.
10. Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and
diastolic, and cardiovascular risks. US population data. Arch
Intern Med 1993;15:598-615.
11. Farmer JA, Gotto AM: Dyslipidemia and other risk factors for
coronary artery disease. In: Braunwald (ed). Heart Disease: A
Textbook of Cardiovascular Medicine. 5th edition.
Philadelphia: WB Saunders; 1997;1126-60.
12. Scheuner MT. Genetic predisposition to coronary artery
disease. Curr Opin Cardiol 2001;16:251-60.
13. Rosenson RS, Koenig W. Utility of inflammatory markers in
the management of coronary artery disease. Am J Cardiol
2003 ;92:10i-8i.
14. Ediz B, Kan İ, Ercan İ. Türetilmiş verilere lojistik regresyon
ve ayırma analizi uygulandığında elde edilen doğru sınıflandırma oranları, IV. Ulusal Biyoistatistik Kongre Bildirisi, Ankara Üniversitesi, 23-24 Eylül 1999.
15. Özdamar K. Paket Programlar ile İstatistiksel Veri Analizi I,
Eskişehir, 1999.
16. Hosmer DW, Lemeshow S. Applied Logistic Regression, John
Wiley & Sons, 1989.
17. Kaufer E, Factor SM, Frame R, Brodman RF. Pathology of
the radial and internal thoracic arteries used as coronary artery
bypass grafts. Ann Thorac Surg 1997;63:1118-22.
18. Pate RR, Pratt M, Blair SN: Physical activity and public
health. A recommendation from the Centers for Disease
Control and Prevention and the American College of Sports
Medicine. JAMA 1995; 273: 402-7.
19. Ceravolo R, Maio R, Pujia A, Sciacqua A, Ventura G, Costa
MC, Sesti G, Perticone F. Pulse pressure and endothelial
dysfunction in never-treated hypertensive patients. J Am Coll
Cardiol 2003;41:1753-8.
20. Maas R, Boger RH. Old and new cardiovascular risk factors:
from unresolved issues to new opportunities. Atheroscler
Suppl 2003;4:5-17.
21. Dodge JT, Brown BG, Bolson EL, Dodge HT. Lumen
diameter of normal human coronary arteries. İnfluence of age,
sex, anatomic variation, and left ventricular hypertrophy or
dilation. Circulation 1992;86:232-46.
22. Milazzo D, Biasucci LM, Luciani N, Martinelli L, Canosa C,
Schiavello R, Maseri A, Possati G. Elevated levels of Creactive protein before coronary artery bypass grafting predict
recurrence of ischemic events. Am J Cardiol. 1999;84:459-61.
23. Biasucci LM, Liuzzo G, Grillo RL, Caligiuri G, Rebuzzi AG,
Buffon A, Summaria F, Ginnetti F, Fadda G, Maseri A.
Elevated levels of C-reactive protein at discharge in patients
with unstable angina predict recurrent instability. Circulation
1999;99:855-60.
24. Avogaro P, Bittolo Bon G, Cazzolato G, Quinci GB. Are
apolipoproteins better discriminators than lipid for
atherosclerosis? Lancet 1979;1:910-913.
25. Sucu N, Tamer L, Aytaçoğlu BN, Gül A, Dikmengil M, Atik
U. The rol of the Lp (a) in coronary atherosclerosis. T Klin
Kalp Damar Cerrahisi 2002;3:133-6.
26. Weinbrenner T, Cladellas M, Isabel Covas M, Fito M, Tomas
M, Senti M, Bruguera J, Marrugat J. High oxidative stress in
patients with stable coronary heart disease. Atherosclerosis
2003;168:99-106.

Thank you for copying data from http://www.arastirmax.com